Torrent Pharma bet big on JB Chemicals, but can the acquisition deliver?

Torrent Pharma’s ₹25,689-crore acquisition of JB Chemicals boosts its chronic portfolio and expands its global reach. But with debt rising and execution risks looming, the real test is a successful integration.

Markets